Life360 (LIF) plunged ~25% after Q2 earnings despite solid results and unchanged guidance. Read here for a detailed ...

The AMG GW&K Small Cap Core Fund returned 18.19% in Q2 2026, trailing its Russell 2000 benchmark. Read the full analysis for ...

BRT Apartments Corp. remains a Hold due to fair valuation and elevated leverage despite operational improvements. Revenue ...

Prime Medicine possesses promising gene editing technology but faces significant dilution risk and cash constraints. Read ...

PIKTOR’s PI3K/AKT/mTOR endometrial cancer data and 2026 catalysts. Read the latest analysis on the stock here.

The Large Cap Equity Fund's Institutional Class returned 7.03% for the second quarter versus 15.49% for the Bloomberg U.S. 1000 Index. Shortages of key components, including memory and logic ...

Wave Life Sciences trades at 2.45x cash with a $1.2B market cap and no debt but faces intense competition across its RNA therapy pipeline. WVE-007 failed to meet FDA obesity drug benchmarks, causing a ...

My core portfolio is built from consensus across 29 institutional outlooks, emphasizing AI infrastructure, power grids, and diversified US equity exposure via ETFs. The densest consensus in the whole ...

"We just celebrated a particularly milestone-rich period with regulatory approvals for a new robot, both therapeutic and diagnostic catheters, and a digital surgery system," said CEO & Chairman David ...

Good day, everyone, and welcome to the Lumentum Holdings Fourth Quarter and Fiscal Year 2026 Earnings Call. [Operator Instructions] Please also note, today's event is being recorded for replay ...

“Our second quarter results reflect the strength of Black Rock's differentiated operating model and the disciplined execution of our team,” said CEO Mark Davis. “Together, these differentiated ...

Robert Piconi said the quarter reflected “the execution of our strategy” and “commercial execution and capturing the demand being driven by AI compute infrastructure,” adding that this is translating ...